CasNo.138199-71-0,Levofloxacin Hemihydrate,(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid hydrate (2:1)(138199-71-0) Suppliers

0 Metric Ton	Negotiable

Min.Order :0 Metric Ton
Purity: 99% min

Keywords

Quick Details

Appearance:
Application:
PackAge:
ProductionCapacity:|Metric Ton|Day
Storage:
Transportation:

Superiority:

Levofloxacin Hemihydrate
CAS: 138199-71-0
High purity & competitive price

Details:

1. The urogenital system infection, including simple, complexity urinary tract infection and bacterial prostatitis, evaluate the antibiotic susceptibility of neisseria gonorrhoeae urethritis and cervicitis (including enzyme production caused by plant person). 2. Respiratory infections, including sensitive gram negative bacilli bronchial infection caused by acute attack and lung infection. 3. The gastrointestinal tract infection by shigella, salmonella genera and genera and produce intestinal toxin escherichia coli, close moisture single cell bacteria, deputy hemolytic vibrio caused by such as.

4. Typhoid.

5. Bone and joint infection.

6. Skin soft tissue infection.

7. Sepsis and systemic infection.

Specification:

Test Item	Analysis Specification
Description	White or yellow light crystalline powder
Identification	Musculine reaction
Clarity& Colour	conform
Specific rotation	-92°~ -109°
Other Impurities(%)	≤0.5
Loss on drying(%)	≤3
Residue on ignition(%)	≤0.2
Limit of (R)-olfx(%)	≤1.0
Heavy metals(%)	≤0.002
Assay(%)	≥98.5
Conclusion	Qualified